Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis

Dongmei Han; Jianfeng Wang; Guanghui Cheng

doi:10.18632/oncotarget.28416

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis

PDF | How to cite

Oncotarget. 2023; 14:363-363. https://doi.org/10.18632/oncotarget.28416

Metrics: PDF 611 views | ?

Dongmei Han¹, Jianfeng Wang¹ and Guanghui Cheng¹

¹Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, China

Published: April 24, 2023

Copyright: © 2023 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Several images in this paper are duplicates of images in other published papers. An image in panel B of Figure 8 is a duplicate of an image in panel C, Figure 2 of another published paper [1]. An image in panel C, Figure 3 is a duplicate of an image in panel C, Figure 2 of another published paper [2]. Although this article was published earlier than the other articles, the Oncotarget Scientific Integrity Office decided to retract this article given concerns about the reliability of the data. All authors have agreed to this retraction.

REFERENCES

1. Wu Q, Xiang S, Ma J, Hui P, Wang T, Meng W, Shi M, Wang Y. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1. Mol Oncol. 2018; 12:799–813. https://doi.org/10.1002/1878-0261.12187. [PubMed]

2. Fei F, He Y, He S, He Z, Wang Y, Wu G, Li M. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep. 2018; 38:BSR20180420. https://doi.org/10.1042/BSR20180420. [PubMed]. Retraction in: Biosci Rep. 2021; 41:BSR-2018-0420_RET. https://doi.org/10.1042/BSR-2018-0420_RET. [PubMed]

Original article: Oncotarget. 2018; 9:2395–2409. DOI: https://doi.org/10.18632/oncotarget.23416

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28416

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis